OARS funding Neuroscience

"JobsOhio is hosting a town hall meeting to discuss initiatives and strategic assets within the Dayton/Western and Cincinnati/Southwest Ohio region. Join us Thursday, December 17 at 1:30 - 3 p.m. to learn more about our strategy and objectives as well as introduce the advisors and leadership for this sector. JobsOhio's President and CEO, J.P. Nauseef and Managing Director of Military and Federal, Elaine Bryant and will be joined by notable guest speakers who will offer their expertise and alignment on the statewide initiative."

The Science & PINS Prize is awarded for innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine.

NOTE: This is a limited submission opportunity. Please contact Research & Innovation at 9-3600 if you are interested in your proposal being considered for Miami's institutional submission for this opportunity. The goal of this funding opportunity is to accelerate the discovery of additional diagnostic and therapeutic pathways for Gastroparesis by addition of basic and translational research studies to NIDDK's Gastroparesis program. In particular, NIDDK invites applications that will apply recent advances and technologies in immunology, inflammation, microbiology, gastrointestinal physiology and neuroscience to study the complex problem of Gastroparesis.

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Funding Opportunity Announcement (FOA) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.

This Funding Opportunity Announcement (FOA) intends to accelerate the use of scalable technologies and tools to enhance brain cell census research, including the development of technology platforms and/or resources and the generation of spatiotemporal cell census data and/or resources. Applications are expected to address limitations and gaps of existing technologies/tools as a benchmark against which the improvements or competitive advantages of the proposed ones will be measured. The improvements include throughput, sensitivity, selectivity, scalability, spatiotemporal resolution and reproducibility in cell atlas analyses. The projects funded under this FOA will align with the overarching goals of the BRAIN Initiative Cell Census Network (BICCN) and are expected to enable the generation of a large amount of cell census data using the proposed technologies or via collaboration with the BICCN.

The Tourette Association of America (TAA) aims to encourage early career researchers to invest their efforts and expertise in increasing our biological understanding of Tourette Syndrome (TS), pursing clinical research aimed at improving patient care, and developing and testing new therapies.

Grass Fellowships at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, USA, support investigator-designed, independent research projects by scientists early in their career. Supported approaches include neurophysiology, biophysics, integrative neurobiology, neuroethology, neuroanatomy, neuropharmacology, systems neuroscience, cellular and developmental neurobiology, and computational approaches to neural systems. The Foundation also has a longstanding interest in epilepsy-related research.

The purpose of this Funding Opportunity Announcement (FOA) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds ("validated hits") for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIDA, NEI, and/or NIA and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. The main emphasis of projects submitted under this FOA should be the discovery of in vivo chemical probes. Applicants interested in developing cell-based chemical probes may wish to apply using the companion R21 mechanism, (PAR-21-028).

We are looking for ideas that can lead to new multi-grant research portfolios on human flourishing. We are particularly interested in ideas for interdisciplinary scientific research towards discoveries that can promote physical, mental, social, and spiritual well-being. We welcome ideas that bridge gaps between empirical science and the humanities. Such ideas may include (but are not limited to):  Experimental testing of philosophically grounded models of human flourishing; Research on biological complexity in humans, including genetics, epigenetics, and microbiome research; Investigation of key psychological, neuroscientific, or human developmental concepts, such as (but not limited to) altruism, creativity, imagination, narrative, and meta-cognition; Research on cognitive, affective, or social capacities of individuals or groups; Studies of human biological or cultural evolution.

NSF-supported science and engineering research increasingly relies on cutting-edge infrastructure. With its Major Research Instrumentation (MRI) program and Major Multi-user Facilities (Major Facilities) projects, NSF supports infrastructure projects at the lower and higher ends of infrastructure scales across science and engineering research disciplines. The Mid-scale Research Infrastructure Big Idea is intended to provide NSF with an agile, Foundation-wide process to fund experimental research capabilities in the mid-scale range between the MRI and Major Facilities thresholds. NSF defines Research Infrastructure (RI) as any combination of facilities, equipment, instrumentation, or computational hardware or software, and the necessary human capital in support of the same. Major facilities and mid-scale projects are subsets of research infrastructure. The NSF Mid-scale Research Infrastructure-1 Program (Mid-scale RI-1) supports the design or implementation of unique and compelling RI projects. Mid-scale RI-1 implementation projects may include any combination of equipment, instrumentation, cyberinfrastructure, broadly used large-scale datasets, and the commissioning and/or personnel needed to successfully complete the project, or the design efforts intended to lead to eventual implementation of a mid-scale class project. Mid-scale RI-1 design projects will include the design efforts intended to lead to eventual implementation of a mid-scale class RI project. Mid-scale RI-1 projects should fill a research community-defined scientific need or enable a national research priority to be met. Mid-scale RI-projects should also enable US researchers to remain competitive in a global research environment and involve the training of a diverse workforce engaged in the design and implementation of STEM infrastructure.

A. Noam Chomsky Global Connections Awards celebrate the power of human connections. The awards recognize distinguished service to the global mission of the STAR Scholars Network. Several individuals with a deep impact on advancing global, social mobility are recognized every year. We live in a time when innovation and creativity in support of humanity are of great importance. The Star Scholars Network recognizes the commitment of concerned people able and willing to make a difference in the lives of others. Nominations for this award are solicited from around the world. The nominee can be from any field. Beginning in 2020, the Star Scholars Network is committed to promoting transnational research, or collaborative research between scholars of two or more countries (e.g., joint publications, research partnerships, etc.). The Global Connections Awards recognize STAR Scholars for their achievements and distinctive contributions to translational research that demonstrates the very best of scholarly collaboration among scholars around the world. In December 2020, the Star Scholars Network will provide awards in three categories: North Star Medal of Lifetime Achievement, Shining Star Achievement in Research Award, Rising Star Emerging Scholar Certificate

The Ohio Department of Higher Education (ODHE) will make strategic investments to support expanded opportunities for students in Science, Technology, Engineering, Mathematics and Medical (STEMM) fields. The investments will directly impact the ability of the state of Ohio to educate and train students to meet Ohio's career and job opportunities today and tomorrow. Choose Ohio First provides scholarships to students in innovative academic programs developed by Ohio's two-year and four-year, public and private colleges and universities, along with their business partners. The scholarships connect students to work-based learning experiences and careers in STEMM fields in order to recruit and retain these students in Ohio. Choose Ohio First is part of a strategic effort to deepen Ohio's economic strength by increasing the talent pipeline for STEMM-related industries, including computer science, through degree and certificate completion.

Applications should focus on studies that achieve one or more of the following for Parkinson's: - Develop or validate promising biomarkers of disease - Develop or validate prodromal biomarkers - Develop or validate biomarkers of phenoconversion - Develop or validate specific molecular biomarker assays - Analyze and derive candidate biomarkers from existing biological datasets - Develop and support remote assessment strategies that could complement in clinic assessments

Applications should focus on studies that achieve one or more of the following: - In vivo imaging of brain neurofilaments of 4R tau and alpha-synuclein pathology that could be useful as biomarkers of the presence of disease and disease progression and as pharmacodynamic tools for drug development for tauopathies or synucleinopathies - Structure- and ligand-based drug design approaches that use state-of-art computational methods such as the high resolution Cryo-EM structures of disease-relevant tau and alpha-synuclein fibrils and existing Structure Activity Relationship (SAR) on known tau PET ligands or alpha-synuclein PET ligands that are in development We are especially interested in projects to develop alpha-synuclein and tau tracers in parallel.

NAF research grants are for new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias. Research grants are offered primarily as "seed monies" to assist investigators in the early or pilot phase of their studies and as additional support for ongoing investigations on demonstration of need. It is hoped that these studies will be further developed to attract future funding from other sources. Grants are awarded for one year only. The funds granted will be up to $50,000 per award. Applicants for seed-money grants must be faculty members.

"This Funding Opportunity Announcement (FOA) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this FOA, the term "complex" can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ, or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular and circuit mechanisms, these are neither required nor expected. Studies should not attempt to "model" disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components and processes. The resulting paradigms, component pathways and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic target identification. The present announcement (R21 activity code) can be used for applications to develop early stage, high-risk, exploratory approaches or establish proof-of-concept where there is little or no preliminary data."

Through the program, grants of between $50,000 and $150,000 will be awarded to early-career investigators in support of novel research proposals that seek to advance the medical knowledge of migraine. Eligible research includes non-interventional clinical research, with a focus on early diagnosis and treatment, epidemiology, and Patient Reported Outcomes (PRO)/Quality of Life (QoL) measures; biomarkers for diagnosis and prognosis; and preclinical research focused on mechanism of disease (non-calcitonin gene-related peptide [CGRP]- and non-pituitary adenylate cyclase-activating polypeptide [PACAP]-related).

Proposals should relate to the hearing or balance functions of the ear. Both basic and clinical studies may be proposed that investigate aspects of the auditory and vestibular systems including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current or experimental devices (i.e., cochlear implants).

Join BioOhio and the Columbus chapter of the Healthcare Businesswomen's Association (HBA) for a FREE online event - our second Diversity in Bioscience & Healthcare event of 2020, on August 20 at 5 pm. The engaging discussion focuses on the importance of supporting STEM programming at an early age within under-represented communities to encourage careers within the science and healthcare industries. Our special guests include: Frederic Bertley, Ph.D., President & CEO, COSI Kirsten M. Ellenbogen, Ph.D., President & CEO, Great Lakes Science Center Kelly Lewis, Bioscience Technologies Program Instructor, Eastland-Fairfield Career and Technical Schools Lead by the talented Brooke Cartus, Director of Business Development and Senior Facilitator, ImprovEdge! Featuring networking opportunities during the event! This discussion will be held via Zoom. Login instructions are included in your registration confirmation email and reminder emails sent before the event. BioOhio and the Healthcare Business Women's Association (HBA) support all efforts to increase diversity and inclusion within the bioscience and healthcare industries and invite you to join us for our next discussion, Overcoming Obstacles in the Workplace: Making Work Accessible on November 14th, 2020. This event is brought to you by BioOhio in partnership with the Columbus chapter of the Healthcare Businesswomen's Association (HBA) and is made possible by the generous support of BioOhio members AtriCure and BIO.

This Funding Opportunity Announcement (FOA) encourages research to develop task-based behavioral measures that are shown to engage brain systems relevant to anhedonia using neuroimaging or other brain measures with similar spatial resolution. The goal is to identify behavioral tasks that can be used as quantitative tools in future studies of the functional constructs associated with anhedonia and in treatment development. This FOA is for basic science experimental studies involving human participants that fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of brain function in healthy individuals or those with disorders.